Laser Photonics (LASE) Registration filing summary

Company overview and business model

• Vertically integrated manufacturer of photonics-based industrial products, focusing on laser blasting technologies for corrosion control, rust removal, de-coating, and surface conditioning across multiple industries including automotive, aerospace, healthcare, and shipbuilding.

• Expanded into pharmaceutical manufacturing through the acquisition of Control Micro Systems, targeting precision laser solutions for controlled-release medications.

• Business model targets government entities, Fortune 1000 companies, and medium/small businesses, with initiatives like the Service Partner Network to drive adoption among smaller enterprises.

• Holds exclusive global licenses for key laser technologies and leverages affiliate relationships for market access and technology development.

Financial performance and metrics

• Net sales for 2025 were $8.3 million, up from $3.4 million in 2024; however, net sales for the first half of 2026 declined 44.3% year-over-year to $2.7 million.

• Net loss for 2025 was $17.5 million, with a working capital deficit of $3.1 million and cash of $2.2 million as of June 30, 2026.

• The company received a going concern qualification in its 2025 audit due to recurring losses and insufficient revenue.

• Immediate dilution of $1.24 per share is expected for new investors at the assumed offering price.

Use of proceeds and capital allocation

• Plans to allocate approximately 40% of net proceeds to R&D for anti-drone, semiconductor, bulk-to-shape, ESG lasers, and material processing technologies.

• 35% of proceeds earmarked for strategic acquisitions, potentially structured with earn-outs or share issuance.

• 25% of proceeds to be used for general working capital.